NPPB and cardiovascular disorder: Thus, while nanomaterial-based biosensors for NT-proBNP detection hold transformative potential for cardiovascular disease management, overcoming these sensitivity, cost, and practical applicability challenges is vital for their successful implementation in routine clinical practice and broader healthcare settings.